What is the price-to-earnings ratio of Cochlear?
The price-earnings ratio of Cochlear is currently 9.22.
Cochlear P/S 2024
Cochlear P/S
9.22
Ticker
COH.AX
ISIN
AU000000COH5
WKN
898321
As of Aug 3, 2024, Cochlear's P/S ratio stood at 9.22, a 8.98% change from the 8.46 P/S ratio recorded in the previous year.
The Cochlear P/S history
Cochlear Aktienanalyse
What does Cochlear do?
Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Cochlear's P/S Ratio
Cochlear's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Cochlear's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Cochlear's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Cochlear’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Cochlear stock
How has the price-earnings ratio of Cochlear changed compared to last year?
The price-to-earnings ratio of Cochlear has increased by 8.98% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Cochlear high compared to other companies?
Yes, the price-to-earnings ratio of Cochlear is high compared to other companies.
How does an increase in the price-earnings ratio of Cochlear affect the company?
An increase in the price-earnings ratio of Cochlear would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Cochlear affect the company?
A decrease in the price-earnings ratio of Cochlear would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Cochlear?
Some factors that influence the price-earnings ratio of Cochlear are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Cochlear pay?
Over the past 12 months, Cochlear paid a dividend of 4.06 AUD . This corresponds to a dividend yield of about 1.2 %. For the coming 12 months, Cochlear is expected to pay a dividend of 4.25 AUD.
What is the dividend yield of Cochlear?
The current dividend yield of Cochlear is 1.2 %.
When does Cochlear pay dividends?
Cochlear pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Cochlear?
Cochlear paid dividends every year for the past 27 years.
What is the dividend of Cochlear?
For the upcoming 12 months, dividends amounting to 4.25 AUD are expected. This corresponds to a dividend yield of 1.26 %.
In which sector is Cochlear located?
Cochlear is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cochlear kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cochlear from 4/15/2024 amounting to 2.6 AUD, you needed to have the stock in your portfolio before the ex-date on 3/21/2024.
When did Cochlear pay the last dividend?
The last dividend was paid out on 4/15/2024.
What was the dividend of Cochlear in the year 2023?
In the year 2023, Cochlear distributed 3.249 AUD as dividends.
In which currency does Cochlear pay out the dividend?
The dividends of Cochlear are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cochlear
Our stock analysis for Cochlear Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cochlear Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
